Mahendra G. Shah

Mahendra G. Shah, Ph.D. is a highly successful pharmaceutical entrepreneur and executive. From September 2005 to December 2009, he was the founder, chairman and CEO of NextWave Pharmaceuticals, a pediatric focused specialty pharmaceutical company. From 1993 to May 2003 he was the chairman and CEO of First Horizon Pharmaceuticals, a publicly traded specialty pharmaceutical company, where he raised over $200 million and built a very profitable company before it was was sold to Shionogi Pharmaceuticals for $1.4 billion. From 1991 to October 1999, he was vice president of E. J. Financial Enterprises, inc., which manages a fund that invests in healthcare companies. He previously served on the boards of Unimed Pharmaceuticals (UMED), Introgen Therapeutics (INGN), Inpharmakon, Protomed, Structural Bioinformatics, and Zarix. From 1987 to 1991 he was the senior director of new business development with Fujisawa USA (Astellas). Prior to that time he worked in various scientific and management positions with Schering-Plough and Bristol Myers-Squibb. Dr. Shah received his Ph.D. in industrial pharmacy from St. John’s University and his Bachelor’s and Master’s Degree in Pharmacy from L.M. College of Pharmacy in Gujarat, India.

Mahendra G. Shah is the Managing Director at Vivo Capital, based in United States, North America. With a background in Financial Services, Mahendra G. Shah has a rich history of leadership and innovation. Mahendra G. Shah studied Ph.D Industrial Pharmacy @ Saint John's University - Peter J. Tobin College of Business. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.